103 related articles for article (PubMed ID: 22196954)
1. Soluble CD40 ligand, high sensitive C-reactive protein and fetuin-A levels in patients with essential thrombocythemia.
Bilgir F; Bilgir O; Kebapcilar L; Calan M; Ozdemirkiran F; Cinali T; Bozkaya G
Transfus Apher Sci; 2012 Feb; 46(1):67-71. PubMed ID: 22196954
[TBL] [Abstract][Full Text] [Related]
2. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
[TBL] [Abstract][Full Text] [Related]
3. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?
Tapan S; Dogru T; Tasci I; Ercin CN; Ozgurtas T; Erbil MK
Clin Biochem; 2009 Jun; 42(9):791-5. PubMed ID: 19232335
[TBL] [Abstract][Full Text] [Related]
5. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I
Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614
[TBL] [Abstract][Full Text] [Related]
6. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
Ludwiczek O; Kaser A; Tilg H
Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of CD40-CD40 ligand system in patients with essential hypertension.
Yan JC; Ma GS; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2005 May; 355(1-2):191-6. PubMed ID: 15820495
[TBL] [Abstract][Full Text] [Related]
9. Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease.
Azar RR; Kassab R; Zoghbi A; Aboujaoudé S; El-Osta H; Ghorra P; Germanos M; Salamé E
Am Heart J; 2006 Feb; 151(2):521.e1-521.e4. PubMed ID: 16442924
[TBL] [Abstract][Full Text] [Related]
10. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
11. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.
Arellano-Rodrigo E; Alvarez-Larrán A; Reverter JC; Colomer D; Villamor N; Bellosillo B; Cervantes F
Am J Hematol; 2009 Feb; 84(2):102-8. PubMed ID: 19105233
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
13. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis.
Viallard JF; Solanilla A; Gauthier B; Contin C; Déchanet J; Grosset C; Moreau JF; Praloran V; Nurden P; Pellegrin JL; Nurden AT; Ripoche J
Blood; 2002 Apr; 99(7):2612-4. PubMed ID: 11895803
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.
Vivona N; Bivona G; Noto D; Sasso BL; Cefalù AB; Chiarello G; Falletta A; Ciaccio M; Averna MR
Clin Biochem; 2009 Nov; 42(16-17):1713-8. PubMed ID: 19732763
[TBL] [Abstract][Full Text] [Related]
15. [The clinical research of serum soluble CD40L and high sensitivie C-reactive protein in patients with acute coronary syndrome].
Fu HJ; Yuan M; Ren LF; Guo WY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):180-1. PubMed ID: 21315051
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular biomarkers in patients with psoriasis.
Gerdes S; Osadtschy S; Buhles N; Baurecht H; Mrowietz U
Exp Dermatol; 2014 May; 23(5):322-5. PubMed ID: 24660963
[TBL] [Abstract][Full Text] [Related]
17. Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40L.
Nagasawa M; Zhu Y; Isoda T; Tomizawa D; Itoh S; Kajiwara M; Morio T; Nonoyama S; Shimizu N; Mizutani S
Eur J Haematol; 2005 Jan; 74(1):54-60. PubMed ID: 15613107
[TBL] [Abstract][Full Text] [Related]
18. Circulating CD40 ligand is elevated only in patients with more advanced symptomatic peripheral arterial diseases.
Lee WJ; Sheu WH; Chen YT; Liu TJ; Liang KW; Ting CT; Lee WL
Thromb Res; 2006; 118(5):619-26. PubMed ID: 16356539
[TBL] [Abstract][Full Text] [Related]
19. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
